Page last updated: 2024-09-04

xamoterol and Cardiac Failure

xamoterol has been researched along with Cardiac Failure in 74 studies

Research

Studies (74)

Timeframe	Studies, this research(%)	All Research%
pre-1990	33 (44.59)	18.7374
1990's	37 (50.00)	18.2507
2000's	4 (5.41)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Erhardt, PW	1
Böhm, M; Dabew, E; Engelhardt, S; Lohse, MJ; Lorenz, K; Maack, C; Schäfers, HJ; Vlaskin, L	1
Fukushima, M; Matsumoto, M; Matsuyama, T; Ozaki, H; Sato, H	1
Detry, JM; Mancia, G; Pouleur, H	1
Bergler-Klein, J; Glogar, D; Pacher, R; Porenta, G; Pouleur, H; Sochor, H	1
Erhardt, L; Melcher, A; Persson, H; Rythe'n-Alder, E	1
MacFadyen, RJ	1
Bøtker, HE; Jensen, HK; Krusell, LR; Sørensen, EV	1
Shah, R	1
Aiyar, N; Disa, J; Mitchell, MP; Naselsky, DP; Ohlstein, EH; Ruffolo, RR; Stadel, JM; Storer, BL; Willette, RN; Yue, TL	1
Carson, PE	1
Cobelli, F; Febo, O	1
Poole-Wilson, PA; van Veldhuisen, DJ	1
Andréasson, K; Erhardt, L; Eriksson, SV; Hall, C; Hjemdahl, P; Kahan, T; Persson, H; Tidgren, B	1
Hayashida, W; Kawai, C; Kumada, T	1
Lyngborg, K; Mehlsen, J; Svendsen, TL; Tangø, M; Trap-Jensen, J	1
Eber, B; Klein, W; Rotman, B	1
Hori, M; Imai, K; Inoue, M; Kamada, T; Kitabatake, A; Matsuyama, T; Ozaki, H; Sato, H; Yokoyama, H	1
Kupper, W	1
Anfilogoff, NH; Davies, MK; Littler, WA; Murray, RG; Qiang, FX; Virk, SJ	1
Fowler, G; Jamieson, MJ; Petrie, JC; Rawles, J; Smith, FW; Webster, J	1
Bleifeld, W; Erlemeier, HH; Kupper, W	3
Limas, C; Limas, CJ	1
Hasenfuss, G; Holubarsch, C; Just, H; Thierfelder, L	1
Etienne, J; Gurné, O; Pouleur, H; Rousseau, MF; Van Mechelen, H	1
Marlow, HF	3
Fournier, P; Fraysse, JB; Grosgogeat, Y; Komajda, M; Landault, C; Lechat, P; Richaud, M	1
Heng, MK	1
Böhm, M; Erdmann, E; Schwinger, RH	1
Hanet, C; Pouleur, H; Rousseau, MF	2
Crozier, IG; Ikram, H	1
Faergeman, O; Vigholt-Sørensen, E	1
Hasenfuss, G; Holubarsch, CH; Just, HJ; Thierfelder, L	1
Böhm, M; Erdmann, E; Mittmann, C; Schwinger, RH	1
Anfilogoff, NH; Davies, MK; Lawson, N; Littler, WA; Murray, RG; Qiang, F; Virk, SJ	1
Shabetai, R	1
Barker, NP; Bastain, W; Channer, KS; Harry, JD; James, MA; Jones, JV; Marlow, HF; Papouchado, M; Wardleworth, AG	1
Armstrong, C; Blackwood, R; Bryant, B; Garnham, JC; Mayou, RA	1
Heusch, G; Linder, C; Schäfer, S	1
Heinzl, S	1
Timmis, AD	1
Anfilogoff, NH; Davies, MK; Lawson, N; Littler, WA; Murray, RG; Nuttall, A; Sadler, AM; Smith, SJ; Virk, SJ	1
Bounhoure, JP; Doat, P; Fauvel, JM; Grenet, B; Kayanakis, JG; Larouchi, L	1
Francis, GS	1
Davies, MK; Virk, SJ	1
Parmley, WW	1
Gurné, O; Hanet, C; Pouleur, H; Rousseau, MF	1
Waller, DG	1
Bastain, W; Marlow, HF	1
Campbell, RW	1
France, LA; Green, FL; Snow, HM	1
Day, MA; Faergeman, O; Snow, HM; Sørensen, EV	1
Faergeman, O; Snow, HM; Vigholt-Sørensen, E	1
Bhalla, KK; Sykes, CA; Waller, DG; Webster, J; Wray, R	1
Andersen, MF; Faergeman, O; Sorensen, EV; Sterndorff, B	1
Cheron, P; Lavenne, F; Nannan, M; Pouleur, H; Rousseau, MF; Vincent, MF	1
Aumont, MC; Castaigne, A	1
Bastain, W; Petrie, JC; Scott, AK; Webster, J	1
von Olshausen, K	1
Fukuda, K; Handa, S; Kawamura, Y; Nakamura, Y; Ogawa, S	1
Hirokawa, Y; Shibata, A; Watanabe, K	1

Reviews

23 review(s) available for xamoterol and Cardiac Failure

Article	Year
In search of the digitalis replacement. Journal of medicinal chemistry, 1987, Volume: 30, Issue:2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship	1987
Role of the circulating and tissue-based renin-angiotensin system in the development of heart failure: implications for therapy. Cardiology, 1993, Volume: 83, Issue:1-2 Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Enalapril; Heart Failure; Hemodynamics; Humans; Renin-Angiotensin System; Survival Rate; Ventricular Function, Left; Xamoterol	1993
CPMP note for guidance: clinical trials on the medicinal products in the treatment of cardiac failure. Methods and findings in experimental and clinical pharmacology, 1996, Volume: 18 Suppl C Topics: Adrenergic beta-Agonists; Clinical Trials as Topic; Cytochrome P-450 Enzyme System; Follow-Up Studies; Guidelines as Topic; Heart Failure; Humans; Isoenzymes; Phosphodiesterase Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; United Kingdom; Xamoterol	1996
Beta-blocker therapy in heart failure: pathophysiology and clinical results. Current problems in cardiology, 1999, Volume: 24, Issue:7 Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exercise; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Quality of Life; Stroke Volume; Time Factors; Vasodilator Agents; Xamoterol	1999
[Exercise test in the evaluation of the efficacy of drug therapy]. Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2000, Volume: 1, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Digitalis; Evaluation Studies as Topic; Exercise Test; Follow-Up Studies; Heart Failure; Humans; Oxygen Consumption; Plants, Medicinal; Plants, Toxic; Time Factors; Vasodilator Agents; Xamoterol	2000
The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure. International journal of cardiology, 2001, Volume: 80, Issue:1 Topics: Bosentan; Cardiovascular Agents; Deoxyepinephrine; Heart Failure; Humans; Imidazoles; Mibefradil; Pyrazines; Quinolines; Sulfonamides; Xamoterol	2001
[New oral drugs for the treatment of congestive heart failure]. Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50, Issue:2 Topics: Administration, Oral; Cardiotonic Agents; Deoxyepinephrine; Ethanolamines; Heart Failure; Humans; Phosphodiesterase Inhibitors; Piperidines; Propanolamines; Pyrazines; Quinolines; Quinolones; Vasodilator Agents; Xamoterol	1992
Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure. Circulation, 1990, Volume: 81, Issue:2 Suppl Topics: Adrenergic beta-Agonists; Double-Blind Method; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Contraction; Propanolamines; Randomized Controlled Trials as Topic; Sympathetic Nervous System; Xamoterol	1990
[Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency]. Archives des maladies du coeur et des vaisseaux, 1990, Volume: 83, Issue:2 Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Clinical Protocols; Dobutamine; Down-Regulation; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Sympathetic Nervous System; Xamoterol	1990
Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status. Clinical cardiology, 1990, Volume: 13, Issue:3 Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Myocardial Contraction; Propanolamines; Xamoterol	1990
Selective beta-1-adrenoceptor partial agonist treatment for congestive heart failure. Cardiology, 1990, Volume: 77, Issue:5 Topics: Adrenergic beta-Agonists; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Propanolamines; Ventricular Function, Left; Xamoterol	1990
Xamoterol--more trouble than it's worth? Drug and therapeutics bulletin, 1990, Jul-09, Volume: 28, Issue:14 Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Propanolamines; Xamoterol	1990
The efficacy of xamoterol in heart failure of ischemic origin. Journal of cardiovascular pharmacology, 1989, Volume: 14 Suppl 5 Topics: Adrenergic beta-Agonists; Coronary Disease; Heart Failure; Humans; Propanolamines; Xamoterol	1989
[Heart failure. New knowledge on pathophysiology and therapy]. Medizinische Monatsschrift fur Pharmazeuten, 1989, Volume: 12, Issue:5 Topics: Heart; Heart Failure; Hemodynamics; Humans; Propanolamines; Xamoterol	1989
A new look at digoxin in congestive heart failure and sinus rhythm. Postgraduate medical journal, 1989, Volume: 65, Issue:768 Topics: Arrhythmia, Sinus; Blood Circulation; Cardiac Glycosides; Digoxin; Heart Failure; Humans; Myocardial Contraction; Propanolamines; Xamoterol	1989
The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure. American heart journal, 1989, Volume: 118, Issue:3 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Propanolamines; Receptors, Adrenergic, beta; Renin-Angiotensin System; Sympathetic Nervous System; Xamoterol	1989
Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure. British journal of clinical pharmacology, 1989, Volume: 28 Suppl 1 Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Propanolamines; Xamoterol	1989
Treatment of congestive heart failure--state of the art and future trends. British journal of clinical pharmacology, 1989, Volume: 28 Suppl 1 Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Propanolamines; Xamoterol	1989
Focus on diastolic dysfunction: a new approach to heart failure therapy. British journal of clinical pharmacology, 1989, Volume: 28 Suppl 1 Topics: Adrenergic beta-Agonists; Animals; Diastole; Heart Failure; Humans; Myocardial Contraction; Propanolamines; Xamoterol	1989
Long-term studies with xamoterol in heart failure. British journal of clinical pharmacology, 1989, Volume: 28 Suppl 1 Topics: Adrenergic beta-Agonists; Chronic Disease; Heart Failure; Humans; Propanolamines; Xamoterol	1989
The management of heart failure and the scope for new therapies: what role for xamoterol? British journal of clinical pharmacology, 1989, Volume: 28 Suppl 1 Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Propanolamines; Xamoterol	1989
[Cardiac insufficiency. Current treatment]. La Revue du praticien, 1988, Feb-18, Volume: 38, Issue:5 Suppl Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Heart Failure; Humans; Propanolamines; Xamoterol	1988
Xamoterol: stabilising the cardiac beta receptor? Lancet (London, England), 1988, Dec-17, Volume: 2, Issue:8625 Topics: Adrenergic beta-Agonists; Chronic Disease; Heart Failure; Hemodynamics; Humans; Propanolamines; Receptors, Adrenergic, beta; Xamoterol	1988

Trials

27 trial(s) available for xamoterol and Cardiac Failure

Article	Year
Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group. Journal of cardiovascular pharmacology, 1994, Volume: 24, Issue:2 Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Potassium; Prospective Studies; Xamoterol	1994
Effects of beta receptor antagonists in patients with clinical evidence of heart failure after myocardial infarction: double blind comparison of metoprolol and xamoterol. British heart journal, 1995, Volume: 74, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Exercise Test; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Prospective Studies; Xamoterol	1995
Renal effects of xamoterol in patients with moderate heart failure. Cardiovascular drugs and therapy, 1993, Volume: 7, Issue:1 Topics: Aged; Aldosterone; Angiotensin II; Diuresis; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Potassium; Sodium; Xamoterol	1993
Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists. European journal of heart failure, 2002, Volume: 4, Issue:1 Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Chi-Square Distribution; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography, Doppler; Epinephrine; Female; Follow-Up Studies; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Neuropeptide Y; Norepinephrine; Probability; Proportional Hazards Models; Prospective Studies; Survival Rate; Treatment Outcome; Xamoterol	2002
Xamoterol in severe congestive heart failure: long-term oral treatment, a double-blind randomised study. International journal of cardiology, 1992, Volume: 34, Issue:1 Topics: Administration, Oral; Adrenergic beta-Agonists; Aged; Body Weight; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Oxygen Consumption; Propanolamines; Xamoterol	1992
Comparative effects of digoxin and xamoterol on arrhythmias in patients with mild to moderate heart failure. Angiology, 1992, Volume: 43, Issue:4 Topics: Adrenergic beta-Agonists; Analysis of Variance; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digoxin; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Time Factors; Xamoterol	1992
Predominant beta-adrenoceptor blocking effect of xamoterol averaged over the day in patients with mild to moderate heart failure: insight into the mechanism of its long-term clinical efficacy. European journal of clinical pharmacology, 1992, Volume: 43, Issue:5 Topics: Adrenergic beta-Antagonists; Adult; Aged; Circadian Rhythm; Electrocardiography; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Stimulation, Chemical; Sympathetic Nervous System; Time Factors; Xamoterol	1992
Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure. The American journal of cardiology, 1991, May-06, Volume: 67, Issue:12 Topics: Adrenergic beta-Agonists; Adult; Aged; Arrhythmias, Cardiac; Double-Blind Method; Electrocardiography, Ambulatory; Exercise; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Xamoterol	1991
A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure. British journal of clinical pharmacology, 1991, Volume: 31, Issue:3 Topics: Adrenergic beta-Agonists; Aged; Blood Pressure; Cardiac Output; Double-Blind Method; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Iodine Radioisotopes; Kidney; Kidney Function Tests; Male; Middle Aged; Propanolamines; Renal Circulation; Renin; Vascular Resistance; Xamoterol	1991
Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group. Lancet (London, England), 1990, Jul-07, Volume: 336, Issue:8706 Topics: Activities of Daily Living; Adrenergic beta-Agonists; Aged; Analysis of Variance; Blood Pressure; Cardiac Complexes, Premature; Discriminant Analysis; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Multicenter Studies as Topic; Propanolamines; Randomized Controlled Trials as Topic; Research Design; Tachycardia; Xamoterol	1990
Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol. International journal of cardiology, 1990, Volume: 28, Issue:2 Topics: Adrenergic beta-Agonists; Cardiac Complexes, Premature; Coronary Disease; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Renin; Time Factors; Xamoterol	1990
Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure. Circulation, 1990, Volume: 81, Issue:2 Suppl Topics: Adrenergic beta-Agonists; Double-Blind Method; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Contraction; Propanolamines; Randomized Controlled Trials as Topic; Sympathetic Nervous System; Xamoterol	1990
[Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency]. Archives des maladies du coeur et des vaisseaux, 1990, Volume: 83, Issue:2 Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Clinical Protocols; Dobutamine; Down-Regulation; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Sympathetic Nervous System; Xamoterol	1990
[Hemodynamic and humoral changes following intravenous administration of xamoterol in patients with heart failure and coronary heart disease]. Zeitschrift fur Kardiologie, 1990, Volume: 79, Issue:2 Topics: Adrenergic beta-Agonists; Adult; Cardiac Output; Clinical Trials as Topic; Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Norepinephrine; Propanolamines; Renin; Xamoterol	1990
Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol. Cardiology, 1990, Volume: 77, Issue:1 Topics: Administration, Oral; Adrenergic beta-Agonists; Blood Pressure; Cardiac Output; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Male; Norepinephrine; Propanolamines; Pulmonary Wedge Pressure; Randomized Controlled Trials as Topic; Renin; Xamoterol	1990
Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol. British heart journal, 1990, Volume: 64, Issue:3 Topics: Adrenergic beta-Agonists; Adult; Aged; Double-Blind Method; Exercise; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Stroke Volume; Time Factors; Xamoterol	1990
The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure. European heart journal, 1990, Volume: 11, Issue:10 Topics: Adrenergic beta-Agonists; Adult; Aged; Arrhythmias, Cardiac; Circadian Rhythm; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Regression Analysis; Xamoterol	1990
The effect of oral dosing of xamoterol on systolic time intervals in man and xamoterol plasma concentrations in heart failure patients. British journal of clinical pharmacology, 1990, Volume: 29, Issue:4 Topics: Adult; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Heart Failure; Heart Rate; Humans; Male; Myocardial Contraction; Propanolamines; Xamoterol	1990
Exercise capacity and quality of life in the treatment of heart failure. Clinical pharmacology and therapeutics, 1990, Volume: 48, Issue:3 Topics: Adult; Aged; Digoxin; Exercise; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Propanolamines; Quality of Life; Randomized Controlled Trials as Topic; Xamoterol	1990
[Effects of xamoterol in moderate cardiac insufficiency]. Presse medicale (Paris, France : 1983), 1989, Apr-01, Volume: 18, Issue:13 Topics: Adrenergic beta-Agonists; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Placebos; Propanolamines; Random Allocation; Xamoterol	1989
The effects of age, sex and treatment with xamoterol on exercise capacity in patients with heart failure. British journal of clinical pharmacology, 1989, Volume: 28 Suppl 1 Topics: Adrenergic beta-Agonists; Aging; Exercise; Female; Heart Failure; Humans; Male; Propanolamines; Random Allocation; Sex Factors; Xamoterol	1989
Long-term efficacy of xamoterol (a beta 1-adrenoceptor partial agonist) in patients with mild to moderate heart failure. British journal of clinical pharmacology, 1989, Volume: 28 Suppl 1 Topics: Adrenergic beta-Agonists; Aged; Double-Blind Method; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Xamoterol	1989
Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle. British heart journal, 1989, Volume: 62, Issue:5 Topics: Adrenergic beta-Agonists; Adult; Aged; Cardiac Output, Low; Coronary Disease; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Propanolamines; Randomized Controlled Trials as Topic; Xamoterol	1989
Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group. European heart journal, 1989, Volume: 10, Issue:11 Topics: Adrenergic beta-Agonists; Adult; Aged; Angina Pectoris; Coronary Disease; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Propanolamines; Quality of Life; Randomized Controlled Trials as Topic; Single-Blind Method; Xamoterol	1989
Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study. Cardiovascular drugs and therapy, 1989, Volume: 3, Issue:2 Topics: Adrenergic beta-Agonists; Adult; Aged; Digoxin; Double-Blind Method; Echocardiography; Electrocardiography; Exercise Test; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Xamoterol	1989
Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group. Lancet (London, England), 1988, Mar-05, Volume: 1, Issue:8584 Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Digoxin; Double-Blind Method; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Random Allocation; Xamoterol	1988
Xamoterol in heart failure. Lancet (London, England), 1988, May-21, Volume: 1, Issue:8595 Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Propanolamines; Xamoterol	1988

Other Studies

26 other study(ies) available for xamoterol and Cardiac Failure

Article	Year
Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor. Circulation, 2003, Jul-22, Volume: 108, Issue:3 Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atrial Function; Heart Atria; Heart Failure; Heart Rate; Humans; In Vitro Techniques; Male; Metoprolol; Mice; Mice, Transgenic; Middle Aged; Myocardial Contraction; Organ Specificity; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Species Specificity; Xamoterol	2003
[Effect of beta 1-partial agonist(ICI 118-587) on plasma catecholamines level and hemodynamics during exercise in congestive heart failure]. Kokyu to junkan. Respiration & circulation, 1984, Volume: 32, Issue:11 Topics: Adrenergic beta-Agonists; Adult; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Physical Exertion; Propanolamines; Sympathetic Nervous System; Xamoterol	1984
Inotropic drugs of the future. European journal of clinical investigation, 1982, Volume: 12, Issue:6 Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Heart Failure; Humans; Imidazoles; Practolol; Prenalterol; Propanolamines; Xamoterol	1982
In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Bisoprolol; Carbazoles; Carvedilol; Cell Membrane; Cells, Cultured; Cyclic AMP; Decerebrate State; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Iodocyanopindolol; Ligands; Male; Myocardium; Propanolamines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Xamoterol	1999
Interrupting the adaptive changes in congestive heart failure. The American journal of cardiology, 1991, May-06, Volume: 67, Issue:12 Topics: Adrenergic beta-Agonists; Animals; Down-Regulation; Heart; Heart Failure; Heart Rate; Humans; Pressoreceptors; Propanolamines; Rats; Receptors, Adrenergic, beta; Xamoterol	1991
Effects of xamoterol on the reversible cycling of cardiac beta-adrenoceptors. Journal of cardiovascular pharmacology, 1990, Volume: 16, Issue:6 Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cell-Free System; Colchicine; Cytochalasin B; Heart; Heart Failure; Heparin; Isoproterenol; Myocardium; Propanolamines; Protein Kinases; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Xamoterol	1990
Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure. Basic research in cardiology, 1991, Volume: 86 Suppl 1 Topics: Benzazepines; Cardiotonic Agents; Energy Metabolism; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Myocardium; Nitroprusside; Oxygen Consumption; Propanolamines; Vasodilator Agents; Xamoterol	1991
Effects of the beta 1-adrenergic receptor partial agonist xamoterol on left ventricular diastolic function. An evaluation after 1-6 years of oral therapy. Circulation, 1990, Volume: 81, Issue:2 Suppl Topics: Administration, Oral; Adrenergic beta-Agonists; Coronary Disease; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Propanolamines; Time Factors; Xamoterol	1990
The effect of xamoterol in failing human myocardium. European heart journal, 1990, Volume: 11, Issue:4 Topics: Adrenergic beta-Agonists; Aged; Cardiac Surgical Procedures; Electric Stimulation; Female; Heart Failure; Hemodynamics; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Myocardium; Propanolamines; Xamoterol	1990
Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction. European heart journal, 1990, Volume: 11 Suppl A Topics: Adrenergic beta-Agonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Diastole; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Systole; Xamoterol	1990
New evidence on xamoterol. Lancet (London, England), 1990, Jul-07, Volume: 336, Issue:8706 Topics: Adrenergic beta-Agonists; Drug Evaluation; Heart Failure; Humans; Propanolamines; Xamoterol	1990
Xamoterol in severe heart failure. Lancet (London, England), 1990, Aug-25, Volume: 336, Issue:8713 Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Propanolamines; Xamoterol	1990
Myocardial energetics in dilated cardiomyopathy. Clinical cardiology, 1990, Volume: 13, Issue:9 Topics: Adrenergic beta-Agonists; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Circulation; Enoximone; Heart; Heart Failure; Heart Rate; Humans; Imidazoles; Myocardium; Nitroprusside; Oxygen Consumption; Phosphodiesterase Inhibitors; Propanolamines; Pyridazines; Stroke Volume; Vascular Resistance; Vasodilator Agents; Xamoterol	1990
Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity. American heart journal, 1990, Volume: 120, Issue:6 Pt 1 Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Dose-Response Relationship, Drug; Heart Atria; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Myocardium; Pindolol; Propanolamines; Propranolol; Radioligand Assay; Receptors, Adrenergic, beta; Xamoterol	1990
Xamoterol recruits an inotropic reserve in the acutely failing, reperfused canine myocardium without detrimental effects on its subsequent recovery. Naunyn-Schmiedeberg's archives of pharmacology, 1990, Volume: 342, Issue:2 Topics: Animals; Blood Pressure; Dogs; Electrolytes; Female; Heart; Heart Failure; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Propanolamines; Vagotomy; Xamoterol	1990
The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure. European heart journal, 1989, Volume: 10, Issue:3 Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Cardiac Output; Drug Evaluation; Exercise Test; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Propanolamines; Pulmonary Wedge Pressure; Stroke Volume; Time Factors; Vascular Resistance; Xamoterol	1989
Xamoterol, a beta1-adrenoceptor partial agonist: a new approach to heart failure. Proceedings of the 1st International Heart Failure. Interlaken, 1988. British journal of clinical pharmacology, 1989, Volume: 28 Suppl 1 Topics: Adrenergic beta-Agonists; Animals; Heart Failure; Humans; Propanolamines; Xamoterol	1989
Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure. British journal of clinical pharmacology, 1989, Volume: 28 Suppl 1 Topics: Adrenergic beta-Agonists; Blood Pressure; Chronic Disease; Exercise; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Propanolamines; Vascular Resistance; Xamoterol	1989
The effect of age and renal impairment on the pharmacokinetics of xamoterol. British journal of clinical pharmacology, 1989, Volume: 28 Suppl 1 Topics: Adrenergic beta-Agonists; Adult; Aging; Creatinine; Heart Failure; Humans; Kidney Diseases; Male; Middle Aged; Propanolamines; Xamoterol	1989
Xamoterol in mild to moderate heart failure: a subgroup analysis of patients with cardiomegaly but no concomitant angina pectoris. British journal of clinical pharmacology, 1989, Volume: 28 Suppl 1 Topics: Adrenergic beta-Agonists; Angina Pectoris; Cardiomegaly; Exercise Test; Heart Failure; Humans; Propanolamines; Xamoterol	1989
The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure treated with ACE inhibitors. British journal of clinical pharmacology, 1989, Volume: 28 Suppl 1 Topics: Adrenergic beta-Agonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Exercise; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Xamoterol	1989
[Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)]. Annales de medecine interne, 1985, Volume: 136, Issue:3 Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Coronary Disease; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Propanolamines; Tachyphylaxis; Time Factors; Xamoterol	1985
Xamoterol versus digoxin in heart failure. Lancet (London, England), 1988, Apr-16, Volume: 1, Issue:8590 Topics: Adrenergic beta-Agonists; Adult; Aged; Digoxin; Heart Failure; Humans; Middle Aged; Propanolamines; Xamoterol	1988
The effect of age and cardiac failure on xamoterol pharmacokinetics. British journal of clinical pharmacology, 1988, Volume: 25, Issue:2 Topics: Adrenergic beta-Agonists; Adult; Age Factors; Aged; Aged, 80 and over; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Xamoterol	1988
[Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure]. Kokyu to junkan. Respiration & circulation, 1988, Volume: 36, Issue:11 Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Circadian Rhythm; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Xamoterol	1988
Xamoterol in patients with dilated cardiomyopathy: an increase in beta-receptors in lymphocytes. Journal of cardiology, 1988, Volume: 18, Issue:4 Topics: Adaptation, Physiological; Adrenergic beta-Agonists; Adult; Cardiomyopathy, Dilated; Female; Heart Failure; Hemodynamics; Humans; Lymphocytes; Male; Middle Aged; Physical Exertion; Propanolamines; Receptors, Adrenergic, beta; Xamoterol	1988